haloperidol has been researched along with Dementia, Vascular in 9 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Dementia, Vascular: An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Haloperidol-treated patients showed a worsening on Simpson-Angus scale while there was no significant change in this measure in risperidone-treated patients." | 2.70 | A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. ( Chan, WC; Chiu, HF; Choy, CN; Lam, LC; Leung, VP; Li, SW, 2001) |
| "Recently, some cases of neuroleptic malignant syndrome (NMS) in demented patients have been reported, because the demented patients, who were administered neuroleptics due to their abnormal behaviors, have increased." | 2.39 | [Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases]. ( Kimura, T; Yoshida, H, 1994) |
| "However, patients with vascular dementia had an increased risk in hospitalization for a CVE." | 1.34 | Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users. ( Barnett, MJ; Perry, PJ; Wehring, H, 2007) |
| "Haloperidol was abruptly shifted to risperidone 0." | 1.31 | Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects. ( Chang, WH; Chang, YC; Chiu, CC; Huang, MC; Lane, HY; Su, MH, 2002) |
| " In this case, NMS seemed to be induced by bacterial pneumonia after long term administration of LPZ 5 mg per day." | 1.30 | [A study of neuroleptic malignant syndrome in the presenium and senium]. ( Honma, H; Koyama, T; Matsubara, S; Suzuki, I; Watanabe, N, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forlenza, OV | 1 |
| Cretaz, E | 1 |
| Diniz, BS | 1 |
| Sluys, M | 1 |
| Güzelcan, Y | 1 |
| Casteelen, G | 1 |
| de Haan, L | 1 |
| Suh, GH | 1 |
| Shah, A | 1 |
| Barnett, MJ | 1 |
| Wehring, H | 1 |
| Perry, PJ | 1 |
| Kimura, T | 1 |
| Yoshida, H | 1 |
| Suzuki, I | 1 |
| Honma, H | 1 |
| Watanabe, N | 1 |
| Matsubara, S | 1 |
| Koyama, T | 1 |
| Chan, WC | 1 |
| Lam, LC | 1 |
| Choy, CN | 1 |
| Leung, VP | 1 |
| Li, SW | 1 |
| Chiu, HF | 1 |
| Lane, HY | 1 |
| Chang, YC | 1 |
| Su, MH | 1 |
| Chiu, CC | 1 |
| Huang, MC | 1 |
| Chang, WH | 1 |
| González Moneo, MJ | 1 |
| Garrido Barral, A | 1 |
3 reviews available for haloperidol and Dementia, Vascular
| Article | Year |
|---|---|
[The use of antipsychotics in patients with dementia].
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebrovascular Disorders; Dementia; Dementia, | 2008 |
[Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].
Topics: Aged; Aged, 80 and over; Dementia; Dementia, Vascular; Female; Haloperidol; Humans; Male; Middle Age | 1994 |
[Latest therapies for treating dementia].
Topics: Adult; Aged; Alzheimer Disease; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepress | 2002 |
1 trial available for haloperidol and Dementia, Vascular
| Article | Year |
|---|---|
A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia, Vascular; Double-Blind Method; Female; Haloper | 2001 |
5 other studies available for haloperidol and Dementia, Vascular
| Article | Year |
|---|---|
Risperidone-induced leucopenia and neutropenia: a case report.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Delusions; Dementia, Vascular; Hallucinations; Halope | 2004 |
Effect of antipsychotics on mortality in elderly patients with dementia: a 1-year prospective study in a nursing home.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Confidence Intervals; Dementia, Va | 2005 |
Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Databases, Factual; Dementia, Vascul | 2007 |
[A study of neuroleptic malignant syndrome in the presenium and senium].
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Dementia, Vascular; Female; Haloperidol; Humans; Male | 1998 |
Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects.
Topics: Activities of Daily Living; Affect; Aged; Alzheimer Disease; Antipsychotic Agents; Dementia, Vascula | 2002 |